why choose us

First received: August 29, 2023

Clinical Trial: Coagulopathy of Immunodermatologic Diseases

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autoimmune Bullous Dermatosis

Study Type: OBSERVATIONAL


Official Title: Coagulopathy of Immunodermatologic Diseases The Molecular, Prognostic, and Therapeutic Implications of Crosstalk Between Coagulation, Fibrinolysis, and Inflammation in Immune-Mediated Skin Diseases

Brief Summary: This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases.Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases.A one-time sample from 15 general dermatology outpatients who do not have a known or suspected diagnosis of bullous diseases, immune-mediated dermatologic condition, or cutaneous malignancy will also be collected to serve as…

Read more